This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Mouse anti Human CD120a:Alexa Fluor® 647
catalog :
MCA1340A647T
quantity :
25 TESTS/0.25 ml
price :
124 USD
clonality :
monoclonal
host :
mouse
conjugate :
AF647
clone name :
H398
reactivity :
human
application :
flow cytometry
product information
EntityType :
Monoclonal Antibody
EntityCategory :
Antibodies
ProductCode :
MCA1340A647T
Description :
MOUSE ANTI HUMAN CD120a:Alexa Fluor® 647
Specificity :
CD120a
TargetSpecies :
Human
Host :
Mouse
Format :
ALEXA FLUOR® 647
Conjugate/Tag :
ALEXA FLUOR® 647
Isotypes :
IgG2a
Applications :
F
ApplicationTypes :
Flow Cytometry
CrossReactivities :
Rabbit
Clone :
H398
Quantity :
25 TESTS/0.25 ml
QuantityValue :
25
QuantityType :
TESTS/0.25ml
GOAccessions :
GO:0006915, GO:0005576, GO:0005031, GO:0005887, GO:0006693, GO:0006954, GO:0008624, GO:0043123, GO:0044419, GO:0045121, GO:0045944, GO:0050729
GOTerms :
activation of I-kappaB kinase/NF-kappaB cascade, activation of inflammatory response, activation of transcription from RNA polymerase II promoter, apoptotic cell death, apoptotic program, apoptotic programmed cell death, extracellular, GEM domain, glycolipid-enriched membrane domain, GO:0005032, GO:0005033, GO:0008632, interaction with another species, interspecies interaction, interspecies interaction with other organisms, lipid raft, NGF/TNF (6 C-domain) receptor activity, positive regulation of transcription from Pol II promoter, programmed cell death by apoptosis, prostaglandin metabolism, signaling (initiator) caspase activity, stimulation of I-kappaB kinase/NF-kappaB cascade, stimulation of inflammatory response, stimulation of transcription from RNA polymerase II promoter, TNF receptor activity, TNF receptor activity, type I, TNF receptor activity, type II, tumor necrosis factor receptor activity, type I, tumor necrosis factor receptor activity, type II, type I programmed cell death, up regulation of I-kappaB kinase/NF-kappaB cascade, up regulation of inflammatory response, up regulation of transcription from RNA polymerase II promoter, up-regulation of I-kappaB kinase/NF-kappaB cascade, upregulation of I-kappaB kinase/NF-kappaB cascade, upregulation of inflammatory response, up-regulation of inflammatory response, upregulation of transcription from RNA polymerase II promoter, up-regulation of transcription from RNA polymerase II promoter
UniprotAccessions :
P19438
Gene :
TNFRSF1A
GeneID URL :
www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=7132
PublishedSynonyms :
TNF-R1
EntityFormats :
Purified, ALEXA FLUOR® 647, FITC, Preservative Free, RPE
UNSPSC :
12352203
Concentration :
IgG concentration 0.05 mg/ml
ProductForm :
Purified IgG conjugated to Alexa Fluor® 647- liquid
PriceDKK :
923
PrimarySecondary :
Primary
PriceGBP :
88
PriceEUR :
124
PriceUSD :
124 USD
PriceCHF :
145
PriceSEK :
1236
PriceNOK :
1228
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.